ClinicalTrials.govpublic full text
Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients
carcinoma, non-small-cell lung, objective response rate, disease control rate, disease free survival, overall survival, quality of live, nonsmall cell lung cancer, toxicity, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1007345
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.